COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Russian patent published in 2023 - IPC C07D221/16 C07D401/12 C07D409/12 C07D417/12 A61K31/435 A61P35/00 

FIELD: medicine; chemistry.

SUBSTANCE: compound of formula AA, where A, B, R¹, R², R³, R⁶, R⁷, m, n, o, p are defined in the claims, as well as to its pharmaceutical composition and methods of its use.

EFFECT: compound has an NLRP3 modulating effect and can be used to treat a condition, disease, or disorder in which a decrease or increase in NLRP3 activity is one of the causes of the pathology and/or symptoms and/or progression of the condition, disease, or disorder in a subject.

11 cl, 5 dwg, 80 tbl, 870 ex